Stock Trading History of Smith Sandford D
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Smith Sandford D since year 2005.
The trader's CIK number is
1243004.
At the time of this reporting, Smith Sandford D is the Executive Vice President of
Genzyme Corp
(stock ticker symbol
GENZ).
Note that in the past
SMITH SANDFORD D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by Smith Sandford D since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-01-16 | GENZ | Genzyme Corp | Sale | 20,181 | 79.70 | 1,608,425 |
| 2008-01-16 | GENZ | Genzyme Corp | Option Exercise | 20,181 | 49.86 | 1,006,123 |
| 2008-01-11 | GENZ | Genzyme Corp | Option Exercise | 4,719 | 46.24 | 218,206 |
| 2008-01-11 | GENZ | Genzyme Corp | Sale | 4,719 | 79.70 | 376,104 |
| 2008-01-09 | GENZ | Genzyme Corp | Option Exercise | 100 | 46.24 | 4,624 |
| 2008-01-09 | GENZ | Genzyme Corp | Sale | 100 | 79.70 | 7,970 |
| 2007-10-15 | GENZ | Genzyme Corp | Option Exercise | 25,000 | 46.24 | 1,156,000 |
| 2007-10-15 | GENZ | Genzyme Corp | Sale | 25,000 | 74.77 | 1,869,250 |
| 2007-10-10 | GENZ | Genzyme Corp | Sale | 25,000 | 69.80 | 1,745,000 |
| 2007-10-10 | GENZ | Genzyme Corp | Option Exercise | 25,000 | 45.07 | 1,126,750 |
| 2007-06-20 | ARIA | Ariad Pharmaceuticals Inc | Option Exercise | 45,000 | 2.76 | 124,199 |
| 2006-08-31 | GENZ | Genzyme Corp | Option Exercise | 14,220 | 32.52 | 462,434 |
| 2006-08-31 | GENZ | Genzyme Corp | Sale | 11,145 | 66.23 | 738,133 |
| 2006-03-01 | GENZ | Genzyme Corp | Option Exercise | 12,500 | 43.90 | 548,750 |
| 2006-03-01 | GENZ | Genzyme Corp | Sale | 12,500 | 69.12 | 864,000 |
| 2005-07-29 | GENZ | Genzyme Corp | Sale | 1,118 | 71.72 | 80,177 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Sandford D
(Executive Vice President of Genzyme Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
